Andrx slips on CSO departure

ADRX, a developer of oral controlled-release therapeutics, was off $4.95 to $68.05 on Tuesday on news that Chih-Ming Chen retired as CSO and president of ADRX's Andrx Pharmaceuticals subsidiary. Chen ...